Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.
By S. Virtue, Antonio Vidal-Puig. Biochimica et Biophysica Acta, 2010
957 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/470ac3b56b5b657fa79061f68dcdb8d8593fc4e8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- D. Dumesic
- M. Goodarzi
- A. Gore
- Vesna A Chappell
- S. Fenton
- G. Chazenbalk
- A. Nadal
- J. Flaws
Citations in the corpus
- EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. (2015, background): “The inability of WAT to expand as much as necessary and the development of a dysfunctional adipose tissue contributes to obesity and obesity-associated metabolic complications (183).”
- Obesity and female infertility: potential mediators of obesity's impact. (2017, background): “Lipotoxicity plays a role in the development of insulin resistance and a heightened inflammatory state in obese women (40).”
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011, background): “In addition, insulin resistance in PCOS might partially represent dysfunctional adipogenesis from an impaired capacity of regional adipose tissue stores to properly expand with increased dietary caloric intake”